Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: Preliminary observations

American Journal of Neuroradiology

Volumn 18, Issue 2, 1997, Pages 203-218

  Aria Tzika, A ^a,b   Vajapeyam, Sridhar ^b   Barnes, Patrick D ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain neoplasms, magnetic resonance; Children, neoplasms; Magnetic resonance, spectroscopy

Indexed keywords

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR GROWTH; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHOLINE; CREATINE; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 1842365513     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ries LAG, Hankey BF, Miller BA, Hartman AM, Edwards BK. Cancer Statistics Review 1973-88. Washington, DC: National Institutes of Health; 1991. NIH publication 91-2789
2. Bruggers C, Friedman H, Fuller G, et al. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol 1993;21:301-306
3. 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163:1459-1465
4. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5T. Radiology 1990;176:211-220
5. Warach S, Li W, Ronthal M, Edelman RR. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology 1992;182:41-47
6. Aronen H, Gazit I, Louis D, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51
7. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982;79:3523-3526
8. Maudsley A, Hilal S, Perman W, Simon H. Spatially resolved high resolution spectroscopy by four-dimensional NMR. J Magn Reson 1983;51:147-152
9. Bottomley PA, Charles HC, Roemer PB, et al. Human in vivo phosphate metabolite imaging with 31P NMR. Magn Reson Med 1988;7:319-336
10. Lenkinski RE, Holland GA, Allman T, et al. Integrated MR imaging and spectroscopy with chemical shift imaging of P-31 at 1.5 T: initial clinical experience. Radiology 1988;169:201-206
11. Spielman D, Webb P, Macovski A. Water referencing for spectroscopic imaging. Magn Reson Med 1989;12:38-49
12. Vigneron DB, Nelson SJ, Murphy-Boesch J, et al. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite images. Radiology 1990;177:643-649
13. Taylor JS, Vigneron DB, Murphy-Boesch J, et al. Free magnesium levels in normal human brain and brain tumors: 31P chemical shift imaging measurements at 1.5 T. Proc Natl Acad Sci U S A 1991;88:6810-6814
14. Margulis A, Nelson S, Vigneron D. Magnetic resonance spectroscopy. In: MR '91 Internationales Kerspintomographie Symp Garmish-Patenkirchen. Constance, Germany: Schetztor-Verlag; 1991
15. Wald L, Moyher S, Day M, Nelson S, Vigneron D. Proton spectroscopic imaging of the human brain using brain phased array detectors. Magn Reson Med 1995;34:440-445
16. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990; 14:538-546
17. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174
18. Rempp KA, Brix G, Wenz F, Becker CR, Gückel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641
19. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-348
20. Nelson S, Brown T. A new method for automatic quantification of 1-D spectra with low signal to noise ratio. J Magn Reson 1987; 75:229-243
21. Tzika AA, Massoth RJ, Ball WSJ, Majumdar S, Dunn RS, Kirks DR. Cerebral perfusion in children: detection with dynamic contrast-enhanced T2*-weighted MR images. Radiology 1993;187: 449-458
22. van Zijl PC, Moonen CT, Gillen J, et al. Proton magnetic resonance spectroscopy of small lesions (1 ml) localized inside superficial human tumors: a clinical feasibility study. NMR Biomed 1990;3: 227-232
23. Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
24. Frahm J, Bruhn H, Hänicke W, Merboldt K, Mursch K, Markakis E. Localized proton NMR spectroscopy of brain tumors using shortecho time STEAM sequences. J Comput Assist Tomogr 1991;15: 915-922
25. Segebarth CM, Baleriaux DF, Luyten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn Reson Med 1990;13:62-76
26. Langkowski JH, Wieland J, Bomsdorf H, et al. Pre-operative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla: first results. Magn Reson Imaging 1989;7:547-555
27. Alger J, Frank J, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633-641
28. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172: 541-548
29. 31P spectroscopy of large pediatric brain tumors. J Neurosurg 1990;72:65-70
30. Sutton L, Wang Z, Gusnard D, et al. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31: 195-202
31. Tzika AA, Vigneron DB, Ball WS, Dunn RS, Kirks DR. Localized proton MR spectroscopy of the brain in children. J Magn Reson Imaging 1993;3:719-729
32. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182
33. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235: 442-447
34. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1989;82:4-6
35. Rosen BR, Belliveau JW, Aronen HJ, Hamberg LM, Kwong KK, Fordham JA. Functional neuroimaging. In: Kucharczyk J, Moseley ME, Barkovich AJ, eds. Magnetic Resonance Neuroimaging. Boca Raton, Fla: CRC Press; 1994:141-166
36. 1H NMR spectra of the human brain. Proc Natl Acad Sci U S A 1988;85:1821-1825
37. Nadler JV, Cooper JR. N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J Neurochem 1972;19:313-319
38. Koller KJ, Zaczek R, Coyle JT. N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43:1136-1142
39. Barker PB, Breiter SN, Soher BJ, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994;32:157-163
40. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93
41. Arnold DL, Shoubridge EA, Villemure JG, Feindel W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo: preliminary observations on tumor grading. NMR Biomed 1990;3:184-189
42. Luyten P, Marien A, den Hollander J. Acquisition and quantitation in proton spectroscopy. NMR Biomed 1991;4:64-69
43. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992;59:55-61
44. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedman G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709
45. Gill SS, Thomas DGT, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504
46. 1H-magnetic resonance of pediatric posterior fossa tumors in vitro. J Neurosurg 1994;81:443-448
47. Radda G, Bore P, Rajagopalan B. Clinical aspects of NMR spectroscopy. Br Med Bull 1984;40:155-160
48. Barker P, Glickson J, Bryan R. In vivo magnetic resonance spectroscopy of brain tumors. Top Magn Reson Imaging 1993;5:32-45
49. Lazeyras F, Charles HC, Schold C, Fredericks R, Coleman RE. H-1 spectroscopic imaging in gliomas. J Magn Reson Imaging 1992;2(Suppl):71-72
50. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo MR spectroscopy. Radiology 1993;186:745-752
51. Posse S, Schuknecht B, Smith M, Van Zijl P, Herschkowitz N, Moonen C. Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr 1993;17:1-14
52. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study. Neurosurgery 1994;35:606-613